ping an-乐鱼官方网站在线登陆入口

sumitomo became the strategic shareholder with shareholding of 29% held in c&o. c&o board of directors has been restructured and sumitomo corporation will appoint three directors to the c&o board.

the chinese government has recently included four new drug projects being developed by c&o in the major scientific and technological projects for “major new drug initiation”, the first program established by the chinese government in the 11th five-ye